PNC Financial Services Group
SION icon

PNC Financial Services Group’s Sionna Therapeutics SION Stock Holding History

PNC Financial Services Group’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.04K Buy
388
+383
+7,660% +$8.8K ﹤0.01% 4829
2026
Q2 		$220 Sell
5
-11
-69% -$440 ﹤0.01% 5093
2026
Q1 		$641 Buy
16
+11
+220% +$420 ﹤0.01% 4857
2025
Q4 		$206 Hold
5
– – ﹤0.01% 4976
2025
Q3 		$147 Buy
+5
New +$109 ﹤0.01% 4966

Other funds holding SION

Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group's SION Position: Q3 2026 in Review

PNC Financial Services Group increased its Sionna Therapeutics (SION) stake by 7,660% in Q3 2026, buying an estimated $8.8K and bringing the position to 388 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4829.

PNC Financial Services Group first reported a position in SION in Q3 2025 and has held it in 5 quarters since. 60 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • PNC Financial Services Group held 388 shares of Sionna Therapeutics worth $2.04K as of Q3 2026.
  • PNC Financial Services Group bought 383 Sionna Therapeutics shares in Q3 2026, an estimated $8.8K.
  • Sionna Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4829 holding.
  • PNC Financial Services Group first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 60 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.